Tus kws kho mob
QP34-22 Minnesota Senior Health Options (MSHO) Model of Care: Annual Training Requirement Reminder
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1411 - 1420 ntawm 4303
Tus kws kho mob
QP35-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 14, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tus kws kho mob
QP24-22 Join the TruHearing Audiology and Hearing Aid Network
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP25-22 Reminder for New to Market Medical Drugs: Medical Drug Evaluation Process List
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP26-22 Provider Directory Validation (PDV) Tool
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP29-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TavneosTM (avacopan)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP30-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TyrvayaTM (varenicline)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
P17-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022